Company Filing History:
2 out of 6 
1 out of 15,471 
1 out of 314 
Years Active: 2003-2012
Title: Inventor Hiroko Kobayashi: Pioneering Monoclonal Antibody Innovations
Introduction: Hiroko Kobayashi is a notable inventor based in Fukushima, Japan, known for her significant contributions in the field of biotechnology. As the holder of four patents, her work primarily focuses on the development of monoclonal antibodies, which hold great potential for diagnosing and treating various diseases.
Latest Patents: Among her most recent inventions is a monoclonal antibody that specifically recognizes the OPN N-half while avoiding recognition of the full-length OPN. This innovative antibody is characterized by its recognition of a protein or polypeptide with the C-terminal amino acid sequence YGLR (SEQ ID NO: 1). Furthermore, her patent outlines several applications, including methods for measuring OPN N-half, diagnosing diseases associated with it, assessing disease severity, and developing treatment methods for these conditions.
Career Highlights: Hiroko Kobayashi has made significant strides in her professional career through her work at various institutions. Notable among them are her tenures at Immuno-biological Laboratories Co., Ltd. and the University of California, where her research has contributed to advancements in medical science.
Collaborations: Throughout her career, Kobayashi has worked alongside esteemed colleagues such as Masahiro Hasegawa and Tsutomu Seito. Collaborating with talented individuals has enriched her research endeavors and led to impactful innovations in her field.
Conclusion: Hiroko Kobayashi has established herself as a prominent figure in the biotechnology sector, with her patents paving the way for advancements in disease diagnosis and treatment. Her focus on monoclonal antibodies showcases the potential impact of her work on healthcare and highlights the importance of innovation in medical research.